Germany's Lanxess Q1 sales fall 13.9% on weak demand

LANXESS AG

07/05/2026 06:26

Overview

Germany specialty chemicals firm's Q1 sales fell 13.9% yr/yr due to currency and portfolio effects

Adjusted EPS for Q1 dropped to EUR 0.50 from EUR 0.23 in prior year

Company cited persistently challenging market environment and lower sales volumes for decline

Outlook

Lanxess maintains 2026 EBITDA pre exceptionals guidance at EUR 450 mln to EUR 550 mln

Company expects persistently challenging market environment to continue in 2026

Lanxess sees continued economic and geopolitical uncertainties impacting results

Result Drivers

CURRENCY AND PORTFOLIO EFFECTS - Co said sales decline was mainly due to currency shifts and portfolio changes, including sale of Urethane Systems unit

LOWER SALES VOLUMES - Co cited volume-related declines in Specialty Additives and weak demand in Consumer Protection and Advanced Intermediates segments

LOWER PRICES - Co said prices declined due to lower raw material costs, also reducing sales by 2.6%

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
EUR 1.38 bln
Q1 EPS
-EUR 1.63
Q1 Net Income
-EUR 141 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 12 "hold" and 5 "sell" or "strong sell"

The average consensus recommendation for the diversified chemicals peer group is "buy."

Wall Street's median 12-month price target for Lanxess AG is €17.00, about 5.9% below its May 6 closing price of €18.06

The stock recently traded at 35 times the next 12-month earnings vs. a P/E of 38 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)